Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Fatigue 1

Interventions

Methylphenidate 7Modafinil 4Therapeutics 3Exercise 3Acupuncture Therapy 3Surveys and Questionnaires 2Radiotherapy 2Counseling 2Carnitine 2testosterone enanthate 1testosterone 17 beta-cypionate 1exemestane 1Valeriana extract 1Triptorelin Pamoate 1Testosterone 1Taxes 1Tamoxifen 1Sugars 1Relaxation Therapy 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Psychiatric Rehabilitation 1Paclitaxel 1Mental Status and Dementia Tests 1Materia Medica 1Infliximab 1Hypericum extract LI 160 1Gonadotropin-Releasing Hormone 1Escitalopram 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fatigue × testosterone enanthate × Clear all
NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡